
HHLR Advisors is the public-equity arm of Hillhouse, the Asia-focused investment firm founded by Zhang Lei in 2005 with seed capital from the Yale endowment. It is known for long-horizon bets on Chinese consumer and technology companies.
35 positions · Top 10 = 85.7% of portfolio
| Company | % of Portfolio | Activity | Market Value | Shares | Change | Sector |
|---|---|---|---|---|---|---|
LEGN LEGEND BIOTECH CORP | 20.77% | — | $172.8M | 5,984,550 | 0 | Health Care |
FUTU FUTU HLDGS LTD | 19.92% | Increased | $165.8M | 1,768,283 | +348,800 | Financials |
AVBP ARRIVENT BIOPHARMA INC | 16.40% | — | $136.5M | 3,929,117 | 0 | Health Care |
MRVL MARVELL TECHNOLOGY INC | 5.83% | Reduced | $48.5M | 162,933 | −8,100 | Information Technology |
VIPS VIPSHOP HLDGS LTD | 5.53% | Increased | $46.0M | 3,470,400 | +3,345,700 | Consumer Discretionary |
PDD PDD HOLDINGS INC | 4.58% | Reduced | $38.1M | 500,000 | −3,665,029 | Consumer Discretionary |
BEKE KE HLDGS INC | 3.87% | Reduced | $32.2M | 2,218,377 | −2,017,901 | Real Estate |
CTKB CYTEK BIOSCIENCES INC | 3.54% | — | $29.5M | 6,657,030 | 0 | Health Care |
ALMR ALAMAR BIOSCIENCES INC | 3.11% | New | $25.9M | 956,462 | +956,462 | Health Care |
BABA ALIBABA GROUP HLDG LTD | 2.12% | Reduced | $17.7M | 183,934 | −2,269,723 | Consumer Discretionary |
Consecutive quarters up to this filing



















Current 3.11%
+956,462Shares

Current 1.87%
+831,656Shares

Current 0.54%
+34,999Shares

Current 0.17%
+4,800Shares

Current 0.09%
+9,010Shares

+24.57%
+348,800Shares

+2683.00%
+3,345,700Shares

+120.00%
+1,800Shares

+112.62%
+7,444Shares

+33.32%
+2,566Shares

Full Exit
0Shares

Full Exit
0Shares

Full Exit
0Shares

Full Exit
0Shares

Full Exit
0Shares

−4.74%
−8,100Shares

−88.00%
−3,665,029Shares

−47.63%
−2,017,901Shares

−92.50%
−2,269,723Shares

−0.06%
−10Shares
Buy and sell amounts are estimates based on 13F share changes
| Quarter | Total value | Positions | Activity | Net buying (est.) | Largest buy (est.) | Largest sell (est.) |
|---|---|---|---|---|---|---|
Q2 2026Filed 2026-08-14 | $832.1M−50.26% | 35 | New Buy 5 · Additional Buy 6 · Partial Exit 8 · Full Exit 8 | −$910.3M | VIPS$44.4M | PDD$374.5M |
Explore portfolios of other popular investors